WO2010013885A1 - Composition cosmétique contenant un extrait fermenté au sel de matériaux naturels - Google Patents
Composition cosmétique contenant un extrait fermenté au sel de matériaux naturels Download PDFInfo
- Publication number
- WO2010013885A1 WO2010013885A1 PCT/KR2009/002396 KR2009002396W WO2010013885A1 WO 2010013885 A1 WO2010013885 A1 WO 2010013885A1 KR 2009002396 W KR2009002396 W KR 2009002396W WO 2010013885 A1 WO2010013885 A1 WO 2010013885A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bean
- salt
- fermented extract
- sea water
- deep
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 113
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 239000002537 cosmetic Substances 0.000 title claims abstract description 20
- 239000000463 material Substances 0.000 title description 17
- 240000004922 Vigna radiata Species 0.000 claims abstract description 68
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims abstract description 68
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims abstract description 68
- 241001107116 Castanospermum australe Species 0.000 claims abstract description 66
- 235000021279 black bean Nutrition 0.000 claims abstract description 66
- 240000001417 Vigna umbellata Species 0.000 claims abstract description 61
- 235000011453 Vigna umbellata Nutrition 0.000 claims abstract description 61
- 239000013535 sea water Substances 0.000 claims abstract description 60
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 23
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 16
- 230000003712 anti-aging effect Effects 0.000 claims abstract description 9
- 239000005445 natural material Substances 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 7
- 239000003960 organic solvent Substances 0.000 claims description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 27
- 230000000052 comparative effect Effects 0.000 description 21
- 238000004519 manufacturing process Methods 0.000 description 19
- 102000029816 Collagenase Human genes 0.000 description 18
- 108060005980 Collagenase Proteins 0.000 description 18
- 108010050808 Procollagen Proteins 0.000 description 18
- 229960002424 collagenase Drugs 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 230000002829 reductive effect Effects 0.000 description 15
- 235000006708 antioxidants Nutrition 0.000 description 14
- 235000002639 sodium chloride Nutrition 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 230000002401 inhibitory effect Effects 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 238000000855 fermentation Methods 0.000 description 8
- 230000004151 fermentation Effects 0.000 description 8
- 239000000049 pigment Substances 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 7
- 244000046052 Phaseolus vulgaris Species 0.000 description 7
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 206010040954 Skin wrinkling Diseases 0.000 description 5
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 235000010633 broth Nutrition 0.000 description 5
- 238000004113 cell culture Methods 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 239000002304 perfume Substances 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 230000002335 preservative effect Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 229960001295 tocopherol Drugs 0.000 description 5
- 229930003799 tocopherol Natural products 0.000 description 5
- 235000010384 tocopherol Nutrition 0.000 description 5
- 239000011732 tocopherol Substances 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 5
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 4
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 4
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 4
- 229940113124 polysorbate 60 Drugs 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 239000003642 reactive oxygen metabolite Substances 0.000 description 4
- 238000009938 salting Methods 0.000 description 4
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- -1 lipid peroxides Chemical class 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 2
- 102000011779 Nitric Oxide Synthase Type II Human genes 0.000 description 2
- 108010076864 Nitric Oxide Synthase Type II Proteins 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 229940092738 beeswax Drugs 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000037319 collagen production Effects 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 108010075254 C-Peptide Proteins 0.000 description 1
- 101150071146 COX2 gene Proteins 0.000 description 1
- 101100114534 Caenorhabditis elegans ctc-2 gene Proteins 0.000 description 1
- 102000010907 Cyclooxygenase 2 Human genes 0.000 description 1
- 108010037462 Cyclooxygenase 2 Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 238000011891 EIA kit Methods 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 206010018092 Generalised oedema Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 101150000187 PTGS2 gene Proteins 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000011425 bamboo Chemical class 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000003658 preventing hair loss Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Definitions
- the present invention relates to a cosmetic composition containing a fermented extract of natural material, and more particularly to a cosmetic composition, that contains either a salt-fermented extract of at least one of red bean, mung bean and black bean or a salt-fermented extract of a mixture obtained by adding deep-sea water to at least one of red bean, mung bean and black bean, and thus has antioxidant and anti-aging effects.
- the present inventors have conducted studies to prepare an antioxidant and anti-aging cosmetic composition, that contains an active ingredient derived from natural material, is safe for the skin and has excellent antioxidant and anti-aging effects and excellent product stability. As a result, the present inventors have found that a salt-fermented extract prepared through a natural fermentation method of fermenting natural materials after salting the materials has excellent antioxidant and anti-aging effects, thereby completing the present invention.
- An object of the present invention is therefore to provide a cosmetic composition that contains a salt-fermented extract of natural material, and thus has excellent skin antioxidant and anti-aging effects.
- the cosmetic composition that is provided by the present invention contains, as an active ingredient, a salt-fermented extract of at least one selected from the group consisting of red bean, mung bean and black bean.
- the cosmetic composition of the present invention may contain, as an active ingredient, a salt-fermented extract of a mixture obtained by adding deep-sea water to at least one selected from the group consisting of red bean, mung bean and black bean.
- the cosmetic composition of the present invention contains, as an active ingredient, the salt-fermented extract in an amount of 0.0001-30 wt% based on the total weight of the composition.
- the content of the salt-fermented extract is less than 0.0001 wt%, the antioxidant and anti-aging effects of the extract cannot be obtained, and if the content exceeds 30 wt%, the increase in the content does not provide a significant increase in the effects.
- the red bean used in the present invention is generally called Pat in Korean, and has diuretic, anti-inflammatory, wound-draining and fever-alleviating effects and is used for generalized edema, liver cirrhosis, jaundice, swelling, suppurative disease, dropsy, beriberi, diseases symptomized by thirst, dysenteric diarrhea and the like.
- the mung bean used in the present invention is called Andu or Gildu in Korean.
- the mung bean grows well in soil in a warm climate and is 30-80 cm in height.
- the stem has thin and vertical veins and about 10 knots and spreads into branches.
- a pair of seed leaves, and other fresh leaves come out, and then a compound leaf consisting of three small leaves comes out.
- the mung bean is classified, according to the color of the seed, into yellow mung bean, greenish brown mung bean and blackish brown mung bean, wherein green mung bean accounts for 90% of the total mung beans. It contains 53-54% starch and 25-26% protein, is highly nutritious and has a good flavor. It is used to treat skin disease in folk remedies and is known to have fever-alleviating and poison-neutralizing effects.
- the black bean used in the present invention is called Komjung kong or Heuk-dae-doo in Korean.
- the names collectively designate blackish beans rather than designating a certain kind of bean.
- Heuk-tae, Seo-ri-tae and Seo-mok-tae in Korean are specific kinds of black bean.
- black bean has a nutrient content similar to that of general beans, but contains anti-aging ingredients in an amount four times larger than those of general beans and has effects of preventing adult diseases and promoting weight loss.
- the Bon-cho-gang-mok (Chinese medicinal plant book) records that black bean has effects of regulating the kidneys, removing edema, activating blood circulation and neutralizing the poison of all drugs.
- black bean contains cystein essential for hair growth, and thus has the effect of preventing hair loss.
- black bean is known to make the function of kidneys and bladder smooth when continuously administered.
- Deep-sea water used in the present invention is found in deep sea areas having a depth of greater than 200 m, and has few or no organisms or pathogenic bacteria.
- the deep-sea water is stably maintained at low temperature throughout the year, and is rich in nutrient salts essential for the growth of marine plants and has a good mineral balance.
- Salt-fermented extracts of red bean, mung bean and black bean that are used in the present invention are prepared in the following manner.
- Step 1 Fermentation of red bean, mung bean and black bean
- a predetermined amount of salt is added to red bean, mung bean or black bean, and the salted bean is aged and fermented for an extended period of time.
- deep-sea water together with salt may be added to the bean, and then the bean may be salt-fermented.
- deep-sea water is preferably added in an amount of 1-2 l.
- Preferred examples of salt used in the salting process include high-purity sodium chloride, solar salt, rock salt and bamboo salt, and the concentration of salt is preferably 10-30 wt% based on the total weight of the fermented material. If the content of salt is less than 10 wt%, it is difficult to obtain the desired salting effect, and if the content exceeds 30 wt%, the increase in the amount of salt used does not provide a significant increase in the salting effect.
- the fermentation process in the present invention may be performed at a temperature between 4 and 40 °C for a period ranging from 30 days to 1 year, and preferably from 6 months to 1 year, such that sufficient fermentation can occur.
- a salt-fermented extract is collected from the salt-fermented natural material of step 1 using an extraction solvent.
- the extraction solvent used in the present invention may be water or an organic solvent, and preferably one, or a mixture of at least two, selected from the group consisting of purified water, methanol, ethanol, glycerin, ethyl acetate, butylene glycol, propylene glycol, dichloromethane and hexane.
- the extraction temperature is preferably between 10 and 80 °C, and the extraction process is performed for 6-24 hours. If the extraction temperature or extraction time are outside of the above-specified ranges, the extraction efficiency can be reduced or the components of the extract can be changed.
- a liquid-phase material can be obtained by performing cold-water extraction at room temperature, heating and filtration according to a conventional method known in the art.
- solvent evaporation, spray drying or freeze drying may additionally be carried out, thus preparing a salt-fermented extract of red bean, mung bean or black bean or a salt-fermented extract of a mixture obtained by adding deep-sea water to red bean, mung bean or black bean.
- a cosmetic composition containing the salt-fermented extract prepared using the above-described method has antioxidant effects. Also, the cosmetic composition has the effects of promoting procollagen production and inhibiting collagenase expression and can show an excellent effect of reducing skin wrinkling due to the synergistic effect of the two activities.
- the salt-fermented extract according to the present invention is not limited to any particular application and may be used in, for example, health food additives and pharmaceutical compositions in addition to cosmetic compositions.
- a salt-fermented extract of red bean, mung bean or black bean according to the present invention has antioxidant effects. Also, the salt-fermented extract showed the effects of promoting procollagen production and inhibiting collagenase expression and can provide an excellent effect of reducing skin wrinkling due to the synergistic effect of the two activities.
- Example 1 Preparation of salt-fermented extract of red bean, mung bean, black bean and deep-sea water
- the concentrated filtrate was suspended in water, the suspension was extracted five times with 1 l of ether to remove pigments, and the aqueous layer was extracted three times with 500 ml of 1-butanol.
- the resulting total 1-butanol layer was concentrated under reduced pressure to obtain a 1-butanol extract, which was then dissolved in a small amount of methanol.
- the solution was added to a large amount of ethyl acetate, and the produced precipitate was dried, thus obtaining 190 g of a salt-fermented extract of red bean, mung bean, black bean and deep-sea water.
- Example 3 Preparation of salt-fermented extract of mung bean and deep-sea water
- Comparative Example 1 Preparation of fermented extract of red bean, mung bean, black bean and deep-sea water
- the concentrated filtrate was suspended in water, the suspension was extracted five times with 1 l of ether to remove pigments, and the aqueous layer was extracted three times with 500 ml of 1-butanol.
- the resulting total 1-butanol layer was concentrated under reduced pressure to obtain a 1-butanol extract, which was then dissolved in a small amount of methanol.
- the solution was added to a large amount of ethyl acetate, and the produced precipitate was dried, thus obtaining 185 g of a fermented extract of red bean, mung bean, black bean and deep-sea water.
- Comparative Example 2 Preparation of extract of red bean, mung bean, black bean and deep-sea water
- the resulting total 1-butanol layer was concentrated under reduced pressure to obtain a 1-butanol extract, which was then dissolved in a small amount of methanol.
- the solution was added to a large amount of ethyl acetate, and the produced precipitate was dried, thus obtaining 170 g of an extract of red bean, mung bean, black bean and deep-sea water.
- Test Example 1 Test of antioxidant effect (DPPH test)
- the antioxidant activity of the extracts were evaluated by measuring the change in absorbance resulting from a reduction of the organic radical DPPH (1,1-diphenyl-2-picryl hydrazyl) due to oxidization of the antioxidant.
- the degree to which absorbance was reduced due to the inhibition of DPPH oxidation by the extracts obtained in Comparative Examples 1 and 2 and Examples 1 to 7 was measured and compared to that of a control group, and a concentration showing an absorbance 50% lower than the absorbance of the control group was evaluated as an effective antioxidant concentration.
- the salt-fermented extracts of red bean, mung bean and/or black bean, prepared in Examples 1 to 7 of the present invention had a significantly greater antioxidant effect compared to that of the fermented extract of Comparative Example 1 and the simple extract of Comparative Example 2.
- Tocopherol and EGCG which are antioxidant substances, are known to prevent skin aging by regenerating the epidermal cells of the skin.
- human fibroblasts were seeded into a 96-well microtiter plate containing DMEM (Dulbecco's Modified Eagle's Media) medium containing 2.5% fetal bovine serum to a density of 5,000 cells/well and were cultured to a confluence of about 90%. Then, the cells were cultured in serum-free DMEM medium for 24 hours and treated with the extracts of Comparative Examples 1 and 2 and Examples 1 to 7, tocopherol and EGCG, dissolved in serum-free DMEM medium, at a concentration of 10 -4 mole for 24 hours. The cell culture broths were then collected.
- DMEM Dynamic fetal bovine serum
- the collected cell culture broths were measured for collagenase production using a commercially available collagenase measurement device (Amersham Phamasia, USA). First, the collected cell culture broths were placed into a 96-well plate containing primary collagenase antibody applied uniformly thereto and were subjected to an antigen-antibody reaction in a constant-temperature bath for 3 hours.
- chromophore-conjugated secondary collagen antibody was placed into the 96-well plate and allowed to react for 15 minutes. After 15 minutes, a substance inducing color development was added to the 96-well plate, and color development was induced at room temperature for 15 minutes. When 1 M sulfuric acid was added to the 96-well plate to stop the (color development reation), the reaction solution had a yellow color, and the intensity of the yellow color varied depending on the degree of progression of the reaction.
- the absorbance of the 96-well plate having a yellow color was measured at 405 nm using an absorbance spectrometer, and the degree of synthesis of collagenase was calculated according to the following Equation 1.
- the absorbance of the cell culture broth collected from the group not treated with the composition was used as a control. That is, the expression of collagenase in the control group was set as 100, and the expression of collagenase in the group treated with the composition was calculated relative to the control group.
- the calculation results are shown in Table 2 below.
- the salt-fermented extracts of the mixtures of red bean, mung bean or black bean with deep-sea water, prepared in Examples 1 to 4 had a significantly greater collagenase inhibitory activity compared to that of the simple salt-fermented extracts prepared in Examples 5 to 7, and the collagenase expression inhibitory activity of Examples 1 to 4 was excellent compared to that of tocopherol known as an antioxidant substance.
- Test Example 3 Test of the effect of promoting procollagen production
- procollagen production ability of the extracts of natural materials, prepared in Comparative Examples 1 and 2, and the salt-fermented extracts of natural materials, prepared in Examples 1 to 7, were measured comparatively with that of vitamin C.
- Procollagen is a collagen production-inducing substance necessary for collagen production and aging prevention, and if the degree of production of procollagen is high, the degree of production of collagen is also high, and thus the production of skin wrinkles can be prevented.
- vitamin C is known as a component essential for the synthesis of collagen.
- human fibroblasts were seeded into a 96-well microtiter plate containing DMEM (Dulbecco's Modified Eagle's Media) medium containing 2.5% fetal bovine serum to a density of 5,000 cells/well and were cultured to a confluence of about 90%. Then, the cells were cultured in serum-free DMEM medium for 24 hours and treated with the extracts of Comparative Examples 1 and 2 and Examples 1 to 7 and vitamin C, dissolved in serum-free DMEM medium, at a concentration of 10 -4 mole for 24 hours. The cell culture broths were then collected. After 24 hours, the amount of released procollagen in the medium was measured with a procollagen type-1 C-peptide EIA kit (MK101, Takara, Japan).
- DMEM Dynamic Eagle's Media
- the production of procollagen was calculated according to the following Equation 2.
- the production of procollagen collected from the group not treated with the composition was used as a control group. That is, the production of procollagen in the control group was set as 100, and the production of procollagen in the groups treated with the composition was calculated relative to the control group.
- the calculation results are shown in Table 3 below.
- the salt-fermented extracts of the mixtures obtained by adding deep-sea water to red bean, mung bean or black bean, prepared in Examples 1 to 4 had a significantly greater ability of promoting procollagen production compared to that of the simple salt-fermented extracts prepared in Examples 5 to 7, and the procollagen production-promoting ability of Examples 1 to 4 was similar to that of vitamin C known as a component essential for the synthesis of collagen.
- composition examples of a composition containing a salt-fermented extract of a mixture obtained by adding deep-sea water to red bean, mung bean and black bean are described, however the cosmetic composition of the present invention is not limited only to these examples.
- a milk lotion containing the salt-fermented extract of a mixture obtained by adding deep-sea water to red bean, mung bean and black bean of Example 1 was prepared according to the composition shown in Table 4 below.
- a skin lotion containing the salt-fermented extract of a mixture obtained by adding deep-sea water to red bean, mung bean and black bean of Example 1 was prepared according to the composition shown in Table 5 below.
- a nourishing cream containing the salt-fermented extract of a mixture obtained by adding deep-sea water to red bean, mung bean and black bean of Example 1 was prepared according to the composition shown in Table 6 below.
- a massage cream containing the salt-fermented extract of a mixture obtained by adding deep-sea water to red bean, mung bean and black bean of Example 1 was prepared according to the composition shown in Table 7 below.
- Table 7 Components Contents (wt%) Example 1 5.0 Bees wax 10.0 Polysorbate 60 1.5 Sorbitan sesquioleate 0.8 PEG60 hydrogenated castor oil 2.0 Liquid paraffin 40.0 Squalane 5.0 Caprylic/capric triglyceride 4.0 Glycerin 5.0 Butylene glycol 3.0 Propylene glycol 3.0 Triethanolamine 0.2 Preservative, pigment and perfume q.s. Purified water Balance Total 100
- a pack containing the salt-fermented extract of a mixture obtained by adding deep-sea water to red bean, mung bean and black bean of Example 1 was prepared according to the composition shown in Table 8 below.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/056,931 US8268366B2 (en) | 2008-08-01 | 2009-05-07 | Cosmetic composition containing salt-fermented extract of natural materials |
CN2009801296062A CN102105131B (zh) | 2008-08-01 | 2009-05-07 | 含有天然材料的盐-发酵提取物的化妆品组合物 |
JP2011521010A JP5730763B2 (ja) | 2008-08-01 | 2009-05-07 | 天然物の塩漬け発酵抽出物を含有する化粧料組成物 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20080075489 | 2008-08-01 | ||
KR10-2008-0075489 | 2008-08-01 | ||
KR10-2009-0034997 | 2009-04-22 | ||
KR1020090034997A KR101199209B1 (ko) | 2008-08-01 | 2009-04-22 | 천연물의 염장 발효 추출물을 함유하는 화장료 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010013885A1 true WO2010013885A1 (fr) | 2010-02-04 |
Family
ID=41610562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2009/002396 WO2010013885A1 (fr) | 2008-08-01 | 2009-05-07 | Composition cosmétique contenant un extrait fermenté au sel de matériaux naturels |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2010013885A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013103936A (ja) * | 2011-11-11 | 2013-05-30 | Amorepacific Corp | 塩蔵発酵高麗人蔘抽出物を含む組成物 |
CN115089529A (zh) * | 2022-08-03 | 2022-09-23 | 肽源(广州)生物科技有限公司 | 一种具有祛痘功效的绿豆皮发酵产物及其制备方法和应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100281011B1 (ko) * | 1997-11-06 | 2001-02-01 | 임병철 | 검은콩 추출물을 함유하는 화장료 조성물 |
WO2001074326A1 (fr) * | 2000-03-31 | 2001-10-11 | Shiseido Company, Ltd. | Agents ameliorant la fonction de barriere cutanee |
KR20020042084A (ko) * | 2000-11-30 | 2002-06-05 | 정진호 | 피부의 탄력을 조절하는 방법 및 그를 위한 조성물 |
WO2002049656A1 (fr) * | 2000-12-19 | 2002-06-27 | Kabushiki Kaisha Yakult Honsha | Preparations externes pour la peau et leur procede de production |
KR20050106710A (ko) * | 2004-05-06 | 2005-11-11 | 주식회사 태평양 | 피부 외용제 조성물 |
KR100635782B1 (ko) * | 2004-11-17 | 2006-10-18 | 주식회사 코리아나화장품 | 거피 흑콩 추출물을 유효성분으로 함유하는 피부자극완화용 화장료 조성물 |
KR20070067542A (ko) * | 2005-12-23 | 2007-06-28 | 주식회사 엘지생활건강 | 팥 추출물을 함유하여 슬리밍에 효과가 있는 화장료 조성물 |
-
2009
- 2009-05-07 WO PCT/KR2009/002396 patent/WO2010013885A1/fr active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100281011B1 (ko) * | 1997-11-06 | 2001-02-01 | 임병철 | 검은콩 추출물을 함유하는 화장료 조성물 |
WO2001074326A1 (fr) * | 2000-03-31 | 2001-10-11 | Shiseido Company, Ltd. | Agents ameliorant la fonction de barriere cutanee |
KR20020042084A (ko) * | 2000-11-30 | 2002-06-05 | 정진호 | 피부의 탄력을 조절하는 방법 및 그를 위한 조성물 |
WO2002049656A1 (fr) * | 2000-12-19 | 2002-06-27 | Kabushiki Kaisha Yakult Honsha | Preparations externes pour la peau et leur procede de production |
KR20050106710A (ko) * | 2004-05-06 | 2005-11-11 | 주식회사 태평양 | 피부 외용제 조성물 |
KR100635782B1 (ko) * | 2004-11-17 | 2006-10-18 | 주식회사 코리아나화장품 | 거피 흑콩 추출물을 유효성분으로 함유하는 피부자극완화용 화장료 조성물 |
KR20070067542A (ko) * | 2005-12-23 | 2007-06-28 | 주식회사 엘지생활건강 | 팥 추출물을 함유하여 슬리밍에 효과가 있는 화장료 조성물 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013103936A (ja) * | 2011-11-11 | 2013-05-30 | Amorepacific Corp | 塩蔵発酵高麗人蔘抽出物を含む組成物 |
CN115089529A (zh) * | 2022-08-03 | 2022-09-23 | 肽源(广州)生物科技有限公司 | 一种具有祛痘功效的绿豆皮发酵产物及其制备方法和应用 |
CN115089529B (zh) * | 2022-08-03 | 2023-07-25 | 肽源(广州)生物科技有限公司 | 一种具有祛痘功效的绿豆皮发酵产物及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8268366B2 (en) | Cosmetic composition containing salt-fermented extract of natural materials | |
KR101452770B1 (ko) | 유산균 발효액을 함유하는 항산화, 미백 및 주름개선 효과를 갖는 화장료 조성물 | |
KR101824770B1 (ko) | 적하수오 부정근 추출물을 함유하는 피부 주름개선 기능성 화장료 조성물 | |
KR20180110939A (ko) | 식물 추출물을 유효성분으로 포함하는 탈모 방지 및 발모 촉진용 조성물 | |
KR20130079220A (ko) | 콩뿌리 추출물을 함유하는 피부 외용제 조성물 | |
KR100762287B1 (ko) | 해양 심층수와 복숭아꽃 추출물을 함유하는 고미네랄 화장료 조성물 | |
WO2010013885A1 (fr) | Composition cosmétique contenant un extrait fermenté au sel de matériaux naturels | |
KR20010096669A (ko) | 미백과 세포 증식효과를 갖는 혼합 식물추출물을 함유한화장료 조성물 | |
KR102223617B1 (ko) | 나비콩꽃, 브델리아 및 수레국화꽃 추출물을 함유하는 피부개선용 화장료 조성물 | |
KR100670238B1 (ko) | 생약재 추출물을 함유하는 피부 주름 개선용 화장료 조성물및 그 제조방법 | |
KR100466379B1 (ko) | 피부미백용 조성물 | |
KR100416400B1 (ko) | 천화분 추출물의 제조방법 및 이를 함유하는 피부 미백용외용제 조성물 | |
KR20040076103A (ko) | 항산화 및 피부노화방지 효능을 갖는 혼합 식물추출물을함유한 화장료 조성물 및 이의 제조방법 | |
JP3113009B2 (ja) | 美白化粧料 | |
KR20160090512A (ko) | 트록세루틴을 함유하는 피부 미백 화장료 조성물 | |
WO2023090708A1 (fr) | Composition comprenant du sirop de grains d'avoine ou un extrait de celui-ci pour l'hydratation de la peau, la réduction des rides et l'antioxydation | |
WO2010058984A2 (fr) | Composition anti-oxydante contenant un extrait traité de chrisanthème ou de pelure de mandarine satsuma | |
WO2024010355A1 (fr) | Composition antivieillissement contenant un extrait de lie de vin de gosori | |
WO2018052152A1 (fr) | Composition anti-âge pour préparation externe pour la peau, contenant un extrait de glycine gracilis germé en tant que principe actif | |
KR102504878B1 (ko) | 능소화 꽃, 매화 꽃, 붉가시나무의 가지 또는 잎의 혼합발효추출물을 유효성분으로 하는 항염, 피부진정 및 가려움증 개선용 화장료 조성물 | |
KR100635785B1 (ko) | 텍토리게닌을 함유하는 화장료 조성물 | |
KR101791425B1 (ko) | 무기환을 유효성분으로 함유하는 미백용 화장료 조성물 | |
KR20070089567A (ko) | 해양 심층수 영양 염류 및 복숭아꽃 추출물을 함유하는고미네랄 인체 세정용 조성물 | |
KR100892273B1 (ko) | 캄페롤-3-o-루티노사이드를 유효 성분으로 함유하는 피부외용제 조성물 | |
WO2012138151A2 (fr) | Composition contenant de l'extrait de calice de fraises pour prévenir la chute des cheveux ou favoriser la croissance des cheveux |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980129606.2 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09803090 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2011521010 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13056931 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09803090 Country of ref document: EP Kind code of ref document: A1 |